Possible involvement of sulfotransferase 1A1 in estragole-induced DNA modification and carcinogenesis in the livers of female mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 749, Issue 1-2, 2012, Pages 23-28

  Suzuki, Yuta ^a,b   Umemura, Takashi ^a   Ishii, Yuji ^a   Hibi, Daisuke ^a,b   Inoue, Tomoki ^a   Jin, Meilan ^a   Sakai, Hiroki ^b   Kodama, Yukio ^a   Nohmi, Takehiko ^a   Yanai, Tokuma ^b   Nishikawa, Akiyoshi ^a   Ogawa, Kumiko ^a  

^a NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

DNA adduct; Estragole; Gpt delta mice; Micronucleus test

Indexed keywords

CORN OIL; ESTRAGOLE; SULFOTRANSFERASE 1A1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA MODIFICATION; ERYTHROCYTE; FEMALE; GENE; GENOTOXICITY; LIQUID CHROMATOGRAPHY; LIVER CARCINOGENESIS; MALE; MICRONUCLEUS; MICRONUCLEUS TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY;

ANIMALS; ANISOLES; ARYLSULFOTRANSFERASE; DNA ADDUCTS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVORING AGENTS; LIVER; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICRONUCLEUS TESTS; MUTAGENS;

MUS; ZEA MAYS;

EID: 84869109930     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2012.07.002     Document Type: Article

References (34)

1. Drinkwater N.R., Miller E.C., Miller N.R., Pitot H.C. Hepatocarcinogenicity of estragole (1-allyl-4-methoxybenzene) and 1'-hydroxyestragole in the mouse and mutagenicity of 1'-acetoxyestragole in bacteria. J. Natl. Cancer Inst. 1976, 57:1323-1331.
2. Miller E.C., Swanson A.B., Philips D.H., Fletcher T.L., Liem A., Miller J.A. Structure-activity studies of the carcinogenicities in the mouse and rat of some naturally occurring and synthetic alkenylbenzene derivatives related to safrole and estragole. Cancer Res. 1983, 43:1124-1134.
3. 1 mice. Cancer Res. 1987, 47:2275-2283.
4. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. I. Adult female CD-1 mice. Carcinogenesis 1984, 5:1613-1622.
5. 32P-post-labelling analysis of DNA adducts formed in the livers of animals treated with safrole, estragole and other naturally-occurring alkenylbenzenes. II. Newborn male B6C3F1 mice. Carcinogenesis 1984, 5:1623-1628.
6. Jeurissen S.M., Punt A., Boersma M.G., Bogaards J.J.P., Fiamegos Y.C., Schilter B., Van Bladeren P.J., Cnubben N.H.P., Rietjens I.M.C.M. Human cytochrome P450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes. Chem. Res. Toxicol. 2007, 20:798-806.
7. Herrmann K., Engst W., Appel K.E., Monien B.H., Glatt H. Identification of human and murine sulfotransferases able to activate hydroxylated metabolites of methyleugenol to mutagens in Salmonella typhimurium and detection of associated DNA adducts using UPLC-MS/MS methods. Mutagenesis 2012, 27:453-462.
8. Zeiger E., Anderson B., Haworth S., Lawlor T., Mortelmans K., Speck W. Salmonella mutagenicity tests: III. Results from the testing of 255 chemicals. Environ. Mutagen. 1987, 9:1-110.
9. Sekizawa J., Shibamoto T. Genotoxicity of safrole-related chemicals in microbial test systems. Mutat. Res. 1982, 101:127-140.
10. Swanson A.B., Chambliss D.D., Blomquist J.C., Miller E.C., Miller J.A. The mutagenicities of safrole, estragole, eugenol, trans-anethole, and some of their known or possible metabolites for Salmonella typhimurium mutants. Mutat. Res. 1979, 60:143-153.
11. Nesslany F., Parent-Massin D., Marzin D. Risk assessment of consumption of methylchavicol and tarragon: the genotoxic potential in vivo and in vitro. Mutat. Res. 2010, 696:1-9.
12. Fennell T.R., Wiseman R.W., Miller J.A., Miller E.C. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J×C3H/HeJ F1 mice. Cancer Res. 1985, 45:5310-5320.
13. 1 mice. Cancer Res. 1987, 47:2275-2283.
14. Nohmi T., Suzuki T., Masumura K. Recent advances in the protocols of transgenic mouse mutation assays. Mutat. Res. 2000, 455:191-215.
15. Ishii Y., Suzuki Y., Hibi D., Jin M., Fukuhara K., Umemura T., Nishikawa A. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose. Chem. Res. Toxicol. 2011, 24:532-541.
16. National Toxicology Program (NTP), NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice, Toxicity Report Series No. 82. NIH Publication No. 11-5966, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Research Triangle Park, NC, 2011.
17. Nishikawa A., Sai K., Okazaki K., Son H.Y., Kanki K., Nakajima M., Kinae N., Nohmi T., Trosko J.E., Inoue T., Hirose M. MX, a by-product of water chlorination, lacks in vivo genotoxicity in gpt delta mice but inhibits gap junctional intercellular communication in rat WB cells. Environ. Mol. Mutagen. 2006, 47:48-55.
18. Umemura T., Kuroiwa Y., Tasaki M., Okamura T., Ishii Y., Kodama Y., Nohmi T., Mitsumori K., Nishikawa A., Hirose M. Detection of oxidative DNA damage, cell proliferation and in vivo mutagenicity induced by dicyclanil, a non-genotoxic carcinogen, using gpt delta mice. Mutat. Res. 2007, 633:46-54.
19. Kanki K., Nishikawa A., Masumura K., Umemura T., Imazawa T., Kitamura Y., Nohmi T., Hirose M. In vivo mutational analysis of liver DNA in gpt delta transgenic rats treated with the hepatocarcinogens N-nitrosopyrrolidine, 2-amino-3-methylimidazo[4,5-f]quinoline, and di(2-ethylhexyl)phthalate. Mol. Carcinog. 2005, 42:9-17.
20. Heddle J.A., Dean S., Nohmi T., Boerrigter M., Casciano D., Douglas G.R., Glickman B.W., Gorelick N.J., Mirsalis J.C., Martus H.J., Skopek T.R., Thybaud V., Tindall K.R., Yajima N. In vivo transgenic mutation assays. Environ. Mol. Mutagen. 2000, 35:253-259.
21. Thybaud V., Dean S., Nohmi T., de Boer J., Douglas G.R., Glickman B.W., Gorelick N.J., Heddle J.A., Heflich R.H., Lambert I., Martus H.J., Mirsalis J.C., Suzuki T., Yajima N. In vivo transgenic mutation assays. Mutat. Res. 2003, 540:141-151.
22. Hayashi M., Sofuni T., Ishidate M. An application of acridine orange fluorescent staining to the micronucleus test. Mutat. Res. 1983, 120:241-247.
23. Smith R.L., Adams T.B., Doull J., Feron V.J., Goodman J.I., Marnett L.J., Portoghese P.S., Waddell W.J., Wagner B.M., Rogers A.E., Caldwell J., Sipes I.G. Safety assessment of allylalkoxybenzene derivatives used as flavouring substances-methyl eugenol and estragole. Food Chem. Toxicol. 2002, 40:851-870.
24. Scientific Committee on Food (SCF), Opinion of the scientific committee on food on estragole (1-allyl-4-methyxybenzene), 2001, Available at: http://ec.europa.eu/food/fs/sc/scf/out104_en.pdf.
25. Y. Suzuki, T. Umemura, D. Hibi, T. Inoue, M. Jin, Y. Ishii, H. Sakai, T. Nohmi, T. Yanai, A. Nishikawa, K. Ogawa, Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats, Arch. Toxicol. (2012), doi:10.1007/s00204-012-0865-8.
26. Phillips D.H., Miller J.A., Miller E.C., Adams B. Structures of the DNA adducts formed in mouse liver after administration of the proximate hepatocarcinogen 1'-hydroxyestragole. Cancer Res. 1981, 41:176-186.
27. Wiseman R.W., Fennell T.R., Miller J.A., Miller E.C. Further characterization of the DNA adducts formed by electrophilic esters of the hepatocarcinogens 1'-hydroxysafrole and 1'-hydroxyestragole in vitro and in mouse liver in vivo, including new adducts at C-8 and N-7 of guanine residues. Cancer Res. 1985, 45:3096-3105.
28. Alnouti Y., Klaassen C.D. Tissue distribution and ontogeny of sulfotransferase enzymes in mice. Toxicol. Sci. 2006, 93:242-255.
29. Gong D.W., Murayama N., Yamazoe Y., Kato R. Hepatic triiodothyronine sulfation and its regulation by growth hormone and triiodothyronine in rats. J. Biochem. 1992, 112:112-116.
30. 2-(trans-isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole. Chem. Res. Toxicol. 2007, 20:991-998.
31. A.T. Cartus, K. Herrmann, L.W. Weishaupt, W. Engst, H. Glatt, D. Schrenk, Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation, Toxicol. Sci. (2012), doi:10.1093/toxsci/kfs181.
32. Zhang Y., Wu X., Guo D., Rechkoblit O., Wang Z. Activities of human DNA polymerase κ in response to the major benzo[a]pyrene DNA adduct: error-free lesion bypass and extension synthesis from opposite the lesion. DNA Repair 2002, 17:559-569.
33. Bichara M., Fuchs R.P.P. DNA binding and mutation spectra of the carcinogen N-2-aminofluorene in Escherichia coli: a correlation between the conformation of the premutagenic lesion and the mutation specificity. J. Mol. Biol. 1985, 183:341-351.
34. Culp S.J., Warbritton A.R., Smith B.A., Li E.E., Beland F.A. DNA adduct measurements, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Carcinogenesis 2000, 21:1433-1440.